^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners

    TEST:
    Lunit SCOPE IO

    Company:
    Lunit
    Type:
    Laboratory Developed Test
    Related tests:

    Details

    Evidence
    News
    Lunit SCOPE IO is used in predicting clinical outcomes of immunotherapy across more than 16 different cancer types. Detects intratumoral TILs and stromal TILs from whole slide images. Classifies three immune phenotype - inflamed, excluded, desert. Calculates AI biomarker score based on the phenotype map. If the score is higher than the cut-off value, it indicates that the patient would be more likely to respond to immunotherapy.
    Cancer:
    Biliary Tract Cancer, Bladder Cancer, Breast Cancer, Cervical Cancer, Colorectal Cancer, Endometrial Cancer, Esophageal Cancer, Gastric Cancer, Head and Neck Cancer, Kidney Cancer, Liver Cancer, Lung Cancer, Melanoma, Ovarian Cancer, Pancreatic Cancer, Prostate Cancer